Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma

Overview of attention for article published in Clinical Epigenetics, June 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 36 Dimensions

Readers on

mendeley: 48 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,385 followers.

Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma. by Bensaid D, Blondy T, Deshayes S, Dehame V, Bertrand P, Grégoire M, Errami M, Blanquart C https://t.co/MTU2qIeBQe

28 Jun 2018

Reply Repost Favourite

My research paper is now available! Please go and check this website and make sure to download my baby paper 😄😄😄 https://t.co/13nhDxmiiE Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma #IASLC #lungcancer #Immunothera

19 Jun 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.